p53 expression is a factor for prognostic assessment in breast sarcoma

Breast Cancer Research and Treatment

Volumn 71, Issue 3, 2002, Pages 193-202

  Maciel, Maria do Socorro ^a   Viegas, Leda C ^b   Nonogaki, Suely ^b   Nishimoto, Inês N ^a   Abrão, Fauzer S ^a   Neto, Mário Mourão ^a   Brentani, M Mitzi ^b  

^a A C CAMARGO CANCER CENTER   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Breast sarcoma; p53; Prognosis

Indexed keywords

PARAFFIN; PROTEIN P53;

ADULT; AGED; ARTICLE; BREAST SARCOMA; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; EVALUATION; FEMALE; FIBROSARCOMA; FISHER EXACT TEST; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIPOSARCOMA; MALIGNANT FIBROUS HISTIOCYTOMA; MENOPAUSE; METASTASIS; PATHOLOGICAL ANATOMY; PRIORITY JOURNAL; PROBABILITY; PROGNOSIS; PROTEIN EXPRESSION; TUMOR VOLUME;

EID: 0036200414     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1014403613747     Document Type: Article

References (50)

1. Breast sarcoma
2. Primary breast sarcoma: A review of 33 cases with immunohistochemistry and prognostic factors
3. Sarcomas of the breast: A mullticenter series of 70 cases
4. Sarcoma and cystosarcoma phyllodes tumors of the breast - A retrospective review of 58 cases
5. An analysis of 78 breast sarcoma patients without distant metastases at presentation. I
6. Sarcomas and related mesenchymal tumors of the breast
7. Sarcoma of the breast: A study of 32 patients with reappraisal of classification and therapy
8. Stromal sarcomas of the breast: A unified approach to connective tissue sarcomas other than cystosarcoma phyllodes
9. Sarcomas of the breast: A clinicopathologic analysis of ten cases
10. The impact of resection margins in the treatment of primary sarcomas of the breast: A clinicopathological study of 8 cases with review of literature
11. Refinement of clinicopathologic staging for localized soft tissue sarcoma of the extremity, a study of 423 adults
12. Histopathologic classificaton of limb sarcomas in relation to prognosis
13. Fibrosarcoma-malignant fibrous histiocytoma of the breast
14. Mesenchymal breast sarcomas: General review
15. Prognostic factors for local recurrence and survival in patients with localized extremity soft-tissue sarcoma
16. Surgical margin in soft tissue sarcoma. The Scandinavian sarcoma group experience
17. Sarcoma of the breast: Implications of the extent of local therapy
18. Sarcoma of the breast: Implications for extent of therapy
19. Role of radiotherapy in sarcoma of the breast-a retrospective review of the M - D Anderson experience
20. Sarcoma of the breast
21. Prevalence and spectrum of germline mutations of the p53 gene among patients with sarcoma
22. p53 abnormalities in different subtypes of human sarcomas
23. Molecular and immunohistochemical p53 status in liposarcoma and malignant fibrous histiocytoma
24. p53 gene mutations and protein expression in human soft tissue sarcomas
25. A comparative study of p53/MDM2 genes alterations and p53/MDM2 proteins immunoreactivity in soft-tissue sarcomas
26. p53 mutation and MDM2 amplification in human soft tissue sarcomas
27. Molecular abnormalities of mdm 2 and p53 genes in adult soft tissue sarcomas
28. Prognostic implications of p53 nuclear overexpression and high proliferation index of Ki-67 in adult soft-tissue sarcomas
29. Nuclear immunoreaction of p53 protein in soft tissue sarcomas: A possible prognostic factor
30. Chromosome 17 abnormalities and TP 53 mutations in adult soft tissue sarcomas
31. Mutant p53 expression, a marker of diminished survival in well-differentiated soft tissue sarcoma
32. Leyomiosarcoma in soft tissue: Examination of p53 status and cell proliferating factors in different locations
33. The p53 gene in soft tissue sarcomas: Prognostic value of DNA sequencing versus immunohistochemistry
34. Prognostic relevance of p53 alterations and Mib-1 proliferation index in subgroups of primary liposarcomas
35. Prognostic value of immunohistochemistry for p53 in primary soft-tissue sarcomas: A multivariate analysis of five antibodies
36. Clinical relevance of pRb and 53 co-overexpression in soft-tissue sarcomas
37. Non parametric estimation from incomplete observations
38. Sarcomas of the breast
39. Breast sarcoma: A clinicopathological review of 25 cases
40. Different patterns of angiogenesis in sarcomas and carcinomas
41. Abnormalities of p53 and p110Rb tumor supressor gene expression in human soft tissue tumors: Correlations with cell proliferation and tumor grade
42. Immunohistochemical detection of bcl-2 and p53 proteins and apoptosis in soft tissue sarcoma: Their correlation with prognosis
43. Histological factors contributing to favorable prognoses of soft tissue sarcomas in premenopausal patients
44. Synovial sarcoma: Identification of low and high risk groups
45. Specificity of seven monoclonal antibodies against p53 evaluated with western blotting, immunohistochemistry, confocal laser scanning microscopy and flow cytometry
46. A comprehensive system to explore p53 mutations
47. MDM2 amplification, p53 mutation, and accumulation of the p53 gene product in malignant fibrous histiocytoma
48. p53 expression in phyllodes tumours is associated with histological features of malignancy but does not predict outcome